Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Mupirocin Market Growth 2022-2028

  • LP 4822794
  • 111 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Mupirocin will have significant change from previous year. According to our (LP Information) latest study, the global Mupirocin market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Mupirocin market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Mupirocin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Mupirocin market, reaching US$ million by the year 2028. As for the Europe Mupirocin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Mupirocin players cover GSK, Medimetriks Pharmaceuticals, Cardinal Health, and Ortho-McNeil Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Mupirocin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Cream

Ointment

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Primary Infection

Secondary Infection

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GSK

Medimetriks Pharmaceuticals

Cardinal Health

Ortho-McNeil Pharmaceutical

Glenmark Pharmaceuticals

Taro Pharmaceuticals

BIOMES PHARMACEUTICALS

H.J. Harkins Company

Directrx

Teva Pharmaceuticals

Fougera Pharmaceuticals

Profcient

Remedy Repack

Lohxa

Nucare Pharmaceuticals

Sino-american Tianjin Shike Pharmaceutical

Hangzhou Zhuyangxin Pharmaceutical

Hubei Renfu Chengtian Pharmaceutical

Hong Kong Aomei Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Mupirocin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Mupirocin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Mupirocin by Country/Region, 2017, 2022 & 2028

2.2 Mupirocin Segment by Type

2.2.1 Cream

2.2.2 Ointment

2.2.3 Other

2.3 Mupirocin Sales by Type

2.3.1 Global Mupirocin Sales Market Share by Type (2017-2022)

2.3.2 Global Mupirocin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Mupirocin Sale Price by Type (2017-2022)

2.4 Mupirocin Segment by Application

2.4.1 Primary Infection

2.4.2 Secondary Infection

2.5 Mupirocin Sales by Application

2.5.1 Global Mupirocin Sale Market Share by Application (2017-2022)

2.5.2 Global Mupirocin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Mupirocin Sale Price by Application (2017-2022)

3 Global Mupirocin by Company

3.1 Global Mupirocin Breakdown Data by Company

3.1.1 Global Mupirocin Annual Sales by Company (2020-2022)

3.1.2 Global Mupirocin Sales Market Share by Company (2020-2022)

3.2 Global Mupirocin Annual Revenue by Company (2020-2022)

3.2.1 Global Mupirocin Revenue by Company (2020-2022)

3.2.2 Global Mupirocin Revenue Market Share by Company (2020-2022)

3.3 Global Mupirocin Sale Price by Company

3.4 Key Manufacturers Mupirocin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Mupirocin Product Location Distribution

3.4.2 Players Mupirocin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Mupirocin by Geographic Region

4.1 World Historic Mupirocin Market Size by Geographic Region (2017-2022)

4.1.1 Global Mupirocin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Mupirocin Annual Revenue by Geographic Region

4.2 World Historic Mupirocin Market Size by Country/Region (2017-2022)

4.2.1 Global Mupirocin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Mupirocin Annual Revenue by Country/Region

4.3 Americas Mupirocin Sales Growth

4.4 APAC Mupirocin Sales Growth

4.5 Europe Mupirocin Sales Growth

4.6 Middle East & Africa Mupirocin Sales Growth

5 Americas

5.1 Americas Mupirocin Sales by Country

5.1.1 Americas Mupirocin Sales by Country (2017-2022)

5.1.2 Americas Mupirocin Revenue by Country (2017-2022)

5.2 Americas Mupirocin Sales by Type

5.3 Americas Mupirocin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Mupirocin Sales by Region

6.1.1 APAC Mupirocin Sales by Region (2017-2022)

6.1.2 APAC Mupirocin Revenue by Region (2017-2022)

6.2 APAC Mupirocin Sales by Type

6.3 APAC Mupirocin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Mupirocin by Country

7.1.1 Europe Mupirocin Sales by Country (2017-2022)

7.1.2 Europe Mupirocin Revenue by Country (2017-2022)

7.2 Europe Mupirocin Sales by Type

7.3 Europe Mupirocin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Mupirocin by Country

8.1.1 Middle East & Africa Mupirocin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Mupirocin Revenue by Country (2017-2022)

8.2 Middle East & Africa Mupirocin Sales by Type

8.3 Middle East & Africa Mupirocin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Mupirocin

10.3 Manufacturing Process Analysis of Mupirocin

10.4 Industry Chain Structure of Mupirocin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Mupirocin Distributors

11.3 Mupirocin Customer

12 World Forecast Review for Mupirocin by Geographic Region

12.1 Global Mupirocin Market Size Forecast by Region

12.1.1 Global Mupirocin Forecast by Region (2023-2028)

12.1.2 Global Mupirocin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Mupirocin Forecast by Type

12.7 Global Mupirocin Forecast by Application

13 Key Players Analysis

13.1 GSK

13.1.1 GSK Company Information

13.1.2 GSK Mupirocin Product Offered

13.1.3 GSK Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GSK Main Business Overview

13.1.5 GSK Latest Developments

13.2 Medimetriks Pharmaceuticals

13.2.1 Medimetriks Pharmaceuticals Company Information

13.2.2 Medimetriks Pharmaceuticals Mupirocin Product Offered

13.2.3 Medimetriks Pharmaceuticals Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Medimetriks Pharmaceuticals Main Business Overview

13.2.5 Medimetriks Pharmaceuticals Latest Developments

13.3 Cardinal Health

13.3.1 Cardinal Health Company Information

13.3.2 Cardinal Health Mupirocin Product Offered

13.3.3 Cardinal Health Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Cardinal Health Main Business Overview

13.3.5 Cardinal Health Latest Developments

13.4 Ortho-McNeil Pharmaceutical

13.4.1 Ortho-McNeil Pharmaceutical Company Information

13.4.2 Ortho-McNeil Pharmaceutical Mupirocin Product Offered

13.4.3 Ortho-McNeil Pharmaceutical Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ortho-McNeil Pharmaceutical Main Business Overview

13.4.5 Ortho-McNeil Pharmaceutical Latest Developments

13.5 Glenmark Pharmaceuticals

13.5.1 Glenmark Pharmaceuticals Company Information

13.5.2 Glenmark Pharmaceuticals Mupirocin Product Offered

13.5.3 Glenmark Pharmaceuticals Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Glenmark Pharmaceuticals Main Business Overview

13.5.5 Glenmark Pharmaceuticals Latest Developments

13.6 Taro Pharmaceuticals

13.6.1 Taro Pharmaceuticals Company Information

13.6.2 Taro Pharmaceuticals Mupirocin Product Offered

13.6.3 Taro Pharmaceuticals Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Taro Pharmaceuticals Main Business Overview

13.6.5 Taro Pharmaceuticals Latest Developments

13.7 BIOMES PHARMACEUTICALS

13.7.1 BIOMES PHARMACEUTICALS Company Information

13.7.2 BIOMES PHARMACEUTICALS Mupirocin Product Offered

13.7.3 BIOMES PHARMACEUTICALS Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 BIOMES PHARMACEUTICALS Main Business Overview

13.7.5 BIOMES PHARMACEUTICALS Latest Developments

13.8 H.J. Harkins Company

13.8.1 H.J. Harkins Company Company Information

13.8.2 H.J. Harkins Company Mupirocin Product Offered

13.8.3 H.J. Harkins Company Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 H.J. Harkins Company Main Business Overview

13.8.5 H.J. Harkins Company Latest Developments

13.9 Directrx

13.9.1 Directrx Company Information

13.9.2 Directrx Mupirocin Product Offered

13.9.3 Directrx Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Directrx Main Business Overview

13.9.5 Directrx Latest Developments

13.10 Teva Pharmaceuticals

13.10.1 Teva Pharmaceuticals Company Information

13.10.2 Teva Pharmaceuticals Mupirocin Product Offered

13.10.3 Teva Pharmaceuticals Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Teva Pharmaceuticals Main Business Overview

13.10.5 Teva Pharmaceuticals Latest Developments

13.11 Fougera Pharmaceuticals

13.11.1 Fougera Pharmaceuticals Company Information

13.11.2 Fougera Pharmaceuticals Mupirocin Product Offered

13.11.3 Fougera Pharmaceuticals Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Fougera Pharmaceuticals Main Business Overview

13.11.5 Fougera Pharmaceuticals Latest Developments

13.12 Profcient

13.12.1 Profcient Company Information

13.12.2 Profcient Mupirocin Product Offered

13.12.3 Profcient Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Profcient Main Business Overview

13.12.5 Profcient Latest Developments

13.13 Remedy Repack

13.13.1 Remedy Repack Company Information

13.13.2 Remedy Repack Mupirocin Product Offered

13.13.3 Remedy Repack Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Remedy Repack Main Business Overview

13.13.5 Remedy Repack Latest Developments

13.14 Lohxa

13.14.1 Lohxa Company Information

13.14.2 Lohxa Mupirocin Product Offered

13.14.3 Lohxa Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Lohxa Main Business Overview

13.14.5 Lohxa Latest Developments

13.15 Nucare Pharmaceuticals

13.15.1 Nucare Pharmaceuticals Company Information

13.15.2 Nucare Pharmaceuticals Mupirocin Product Offered

13.15.3 Nucare Pharmaceuticals Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Nucare Pharmaceuticals Main Business Overview

13.15.5 Nucare Pharmaceuticals Latest Developments

13.16 Sino-american Tianjin Shike Pharmaceutical

13.16.1 Sino-american Tianjin Shike Pharmaceutical Company Information

13.16.2 Sino-american Tianjin Shike Pharmaceutical Mupirocin Product Offered

13.16.3 Sino-american Tianjin Shike Pharmaceutical Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Sino-american Tianjin Shike Pharmaceutical Main Business Overview

13.16.5 Sino-american Tianjin Shike Pharmaceutical Latest Developments

13.17 Hangzhou Zhuyangxin Pharmaceutical

13.17.1 Hangzhou Zhuyangxin Pharmaceutical Company Information

13.17.2 Hangzhou Zhuyangxin Pharmaceutical Mupirocin Product Offered

13.17.3 Hangzhou Zhuyangxin Pharmaceutical Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Hangzhou Zhuyangxin Pharmaceutical Main Business Overview

13.17.5 Hangzhou Zhuyangxin Pharmaceutical Latest Developments

13.18 Hubei Renfu Chengtian Pharmaceutical

13.18.1 Hubei Renfu Chengtian Pharmaceutical Company Information

13.18.2 Hubei Renfu Chengtian Pharmaceutical Mupirocin Product Offered

13.18.3 Hubei Renfu Chengtian Pharmaceutical Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Hubei Renfu Chengtian Pharmaceutical Main Business Overview

13.18.5 Hubei Renfu Chengtian Pharmaceutical Latest Developments

13.19 Hong Kong Aomei Pharmaceutical

13.19.1 Hong Kong Aomei Pharmaceutical Company Information

13.19.2 Hong Kong Aomei Pharmaceutical Mupirocin Product Offered

13.19.3 Hong Kong Aomei Pharmaceutical Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Hong Kong Aomei Pharmaceutical Main Business Overview

13.19.5 Hong Kong Aomei Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Mupirocin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Mupirocin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Cream

Table 4. Major Players of Ointment

Table 5. Major Players of Other

Table 6. Global Mupirocin Sales by Type (2017-2022) & (KG)

Table 7. Global Mupirocin Sales Market Share by Type (2017-2022)

Table 8. Global Mupirocin Revenue by Type (2017-2022) & ($ million)

Table 9. Global Mupirocin Revenue Market Share by Type (2017-2022)

Table 10. Global Mupirocin Sale Price by Type (2017-2022) & (US$/G)

Table 11. Global Mupirocin Sales by Application (2017-2022) & (KG)

Table 12. Global Mupirocin Sales Market Share by Application (2017-2022)

Table 13. Global Mupirocin Revenue by Application (2017-2022)

Table 14. Global Mupirocin Revenue Market Share by Application (2017-2022)

Table 15. Global Mupirocin Sale Price by Application (2017-2022) & (US$/G)

Table 16. Global Mupirocin Sales by Company (2020-2022) & (KG)

Table 17. Global Mupirocin Sales Market Share by Company (2020-2022)

Table 18. Global Mupirocin Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Mupirocin Revenue Market Share by Company (2020-2022)

Table 20. Global Mupirocin Sale Price by Company (2020-2022) & (US$/G)

Table 21. Key Manufacturers Mupirocin Producing Area Distribution and Sales Area

Table 22. Players Mupirocin Products Offered

Table 23. Mupirocin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Mupirocin Sales by Geographic Region (2017-2022) & (KG)

Table 27. Global Mupirocin Sales Market Share Geographic Region (2017-2022)

Table 28. Global Mupirocin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Mupirocin Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Mupirocin Sales by Country/Region (2017-2022) & (KG)

Table 31. Global Mupirocin Sales Market Share by Country/Region (2017-2022)

Table 32. Global Mupirocin Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Mupirocin Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Mupirocin Sales by Country (2017-2022) & (KG)

Table 35. Americas Mupirocin Sales Market Share by Country (2017-2022)

Table 36. Americas Mupirocin Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Mupirocin Revenue Market Share by Country (2017-2022)

Table 38. Americas Mupirocin Sales by Type (2017-2022) & (KG)

Table 39. Americas Mupirocin Sales Market Share by Type (2017-2022)

Table 40. Americas Mupirocin Sales by Application (2017-2022) & (KG)

Table 41. Americas Mupirocin Sales Market Share by Application (2017-2022)

Table 42. APAC Mupirocin Sales by Region (2017-2022) & (KG)

Table 43. APAC Mupirocin Sales Market Share by Region (2017-2022)

Table 44. APAC Mupirocin Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Mupirocin Revenue Market Share by Region (2017-2022)

Table 46. APAC Mupirocin Sales by Type (2017-2022) & (KG)

Table 47. APAC Mupirocin Sales Market Share by Type (2017-2022)

Table 48. APAC Mupirocin Sales by Application (2017-2022) & (KG)

Table 49. APAC Mupirocin Sales Market Share by Application (2017-2022)

Table 50. Europe Mupirocin Sales by Country (2017-2022) & (KG)

Table 51. Europe Mupirocin Sales Market Share by Country (2017-2022)

Table 52. Europe Mupirocin Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Mupirocin Revenue Market Share by Country (2017-2022)

Table 54. Europe Mupirocin Sales by Type (2017-2022) & (KG)

Table 55. Europe Mupirocin Sales Market Share by Type (2017-2022)

Table 56. Europe Mupirocin Sales by Application (2017-2022) & (KG)

Table 57. Europe Mupirocin Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Mupirocin Sales by Country (2017-2022) & (KG)

Table 59. Middle East & Africa Mupirocin Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Mupirocin Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Mupirocin Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Mupirocin Sales by Type (2017-2022) & (KG)

Table 63. Middle East & Africa Mupirocin Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Mupirocin Sales by Application (2017-2022) & (KG)

Table 65. Middle East & Africa Mupirocin Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Mupirocin

Table 67. Key Market Challenges & Risks of Mupirocin

Table 68. Key Industry Trends of Mupirocin

Table 69. Mupirocin Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Mupirocin Distributors List

Table 72. Mupirocin Customer List

Table 73. Global Mupirocin Sales Forecast by Region (2023-2028) & (KG)

Table 74. Global Mupirocin Sales Market Forecast by Region

Table 75. Global Mupirocin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Mupirocin Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Mupirocin Sales Forecast by Country (2023-2028) & (KG)

Table 78. Americas Mupirocin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Mupirocin Sales Forecast by Region (2023-2028) & (KG)

Table 80. APAC Mupirocin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Mupirocin Sales Forecast by Country (2023-2028) & (KG)

Table 82. Europe Mupirocin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Mupirocin Sales Forecast by Country (2023-2028) & (KG)

Table 84. Middle East & Africa Mupirocin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Mupirocin Sales Forecast by Type (2023-2028) & (KG)

Table 86. Global Mupirocin Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Mupirocin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Mupirocin Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Mupirocin Sales Forecast by Application (2023-2028) & (KG)

Table 90. Global Mupirocin Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Mupirocin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Mupirocin Revenue Market Share Forecast by Application (2023-2028)

Table 93. GSK Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 94. GSK Mupirocin Product Offered

Table 95. GSK Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 96. GSK Main Business

Table 97. GSK Latest Developments

Table 98. Medimetriks Pharmaceuticals Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 99. Medimetriks Pharmaceuticals Mupirocin Product Offered

Table 100. Medimetriks Pharmaceuticals Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 101. Medimetriks Pharmaceuticals Main Business

Table 102. Medimetriks Pharmaceuticals Latest Developments

Table 103. Cardinal Health Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 104. Cardinal Health Mupirocin Product Offered

Table 105. Cardinal Health Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 106. Cardinal Health Main Business

Table 107. Cardinal Health Latest Developments

Table 108. Ortho-McNeil Pharmaceutical Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 109. Ortho-McNeil Pharmaceutical Mupirocin Product Offered

Table 110. Ortho-McNeil Pharmaceutical Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 111. Ortho-McNeil Pharmaceutical Main Business

Table 112. Ortho-McNeil Pharmaceutical Latest Developments

Table 113. Glenmark Pharmaceuticals Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 114. Glenmark Pharmaceuticals Mupirocin Product Offered

Table 115. Glenmark Pharmaceuticals Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 116. Glenmark Pharmaceuticals Main Business

Table 117. Glenmark Pharmaceuticals Latest Developments

Table 118. Taro Pharmaceuticals Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 119. Taro Pharmaceuticals Mupirocin Product Offered

Table 120. Taro Pharmaceuticals Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 121. Taro Pharmaceuticals Main Business

Table 122. Taro Pharmaceuticals Latest Developments

Table 123. BIOMES PHARMACEUTICALS Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 124. BIOMES PHARMACEUTICALS Mupirocin Product Offered

Table 125. BIOMES PHARMACEUTICALS Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 126. BIOMES PHARMACEUTICALS Main Business

Table 127. BIOMES PHARMACEUTICALS Latest Developments

Table 128. H.J. Harkins Company Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 129. H.J. Harkins Company Mupirocin Product Offered

Table 130. H.J. Harkins Company Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 131. H.J. Harkins Company Main Business

Table 132. H.J. Harkins Company Latest Developments

Table 133. Directrx Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 134. Directrx Mupirocin Product Offered

Table 135. Directrx Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 136. Directrx Main Business

Table 137. Directrx Latest Developments

Table 138. Teva Pharmaceuticals Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 139. Teva Pharmaceuticals Mupirocin Product Offered

Table 140. Teva Pharmaceuticals Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 141. Teva Pharmaceuticals Main Business

Table 142. Teva Pharmaceuticals Latest Developments

Table 143. Fougera Pharmaceuticals Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 144. Fougera Pharmaceuticals Mupirocin Product Offered

Table 145. Fougera Pharmaceuticals Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 146. Fougera Pharmaceuticals Main Business

Table 147. Fougera Pharmaceuticals Latest Developments

Table 148. Profcient Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 149. Profcient Mupirocin Product Offered

Table 150. Profcient Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 151. Profcient Main Business

Table 152. Profcient Latest Developments

Table 153. Remedy Repack Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 154. Remedy Repack Mupirocin Product Offered

Table 155. Remedy Repack Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 156. Remedy Repack Main Business

Table 157. Remedy Repack Latest Developments

Table 158. Lohxa Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 159. Lohxa Mupirocin Product Offered

Table 160. Lohxa Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 161. Lohxa Main Business

Table 162. Lohxa Latest Developments

Table 163. Nucare Pharmaceuticals Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 164. Nucare Pharmaceuticals Mupirocin Product Offered

Table 165. Nucare Pharmaceuticals Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 166. Nucare Pharmaceuticals Main Business

Table 167. Nucare Pharmaceuticals Latest Developments

Table 168. Sino-american Tianjin Shike Pharmaceutical Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 169. Sino-american Tianjin Shike Pharmaceutical Mupirocin Product Offered

Table 170. Sino-american Tianjin Shike Pharmaceutical Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 171. Sino-american Tianjin Shike Pharmaceutical Main Business

Table 172. Sino-american Tianjin Shike Pharmaceutical Latest Developments

Table 173. Hangzhou Zhuyangxin Pharmaceutical Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 174. Hangzhou Zhuyangxin Pharmaceutical Mupirocin Product Offered

Table 175. Hangzhou Zhuyangxin Pharmaceutical Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 176. Hangzhou Zhuyangxin Pharmaceutical Main Business

Table 177. Hangzhou Zhuyangxin Pharmaceutical Latest Developments

Table 178. Hubei Renfu Chengtian Pharmaceutical Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 179. Hubei Renfu Chengtian Pharmaceutical Mupirocin Product Offered

Table 180. Hubei Renfu Chengtian Pharmaceutical Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 181. Hubei Renfu Chengtian Pharmaceutical Main Business

Table 182. Hubei Renfu Chengtian Pharmaceutical Latest Developments

Table 183. Hong Kong Aomei Pharmaceutical Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors

Table 184. Hong Kong Aomei Pharmaceutical Mupirocin Product Offered

Table 185. Hong Kong Aomei Pharmaceutical Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 186. Hong Kong Aomei Pharmaceutical Main Business

Table 187. Hong Kong Aomei Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Mupirocin

Figure 2. Mupirocin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Mupirocin Sales Growth Rate 2017-2028 (KG)

Figure 7. Global Mupirocin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Mupirocin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Cream

Figure 10. Product Picture of Ointment

Figure 11. Product Picture of Other

Figure 12. Global Mupirocin Sales Market Share by Type in 2021

Figure 13. Global Mupirocin Revenue Market Share by Type (2017-2022)

Figure 14. Mupirocin Consumed in Primary Infection

Figure 15. Global Mupirocin Market: Primary Infection (2017-2022) & (KG)

Figure 16. Mupirocin Consumed in Secondary Infection

Figure 17. Global Mupirocin Market: Secondary Infection (2017-2022) & (KG)

Figure 18. Global Mupirocin Sales Market Share by Application (2017-2022)

Figure 19. Global Mupirocin Revenue Market Share by Application in 2021

Figure 20. Mupirocin Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Mupirocin Revenue Market Share by Company in 2021

Figure 22. Global Mupirocin Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Mupirocin Revenue Market Share by Geographic Region in 2021

Figure 24. Global Mupirocin Sales Market Share by Region (2017-2022)

Figure 25. Global Mupirocin Revenue Market Share by Country/Region in 2021

Figure 26. Americas Mupirocin Sales 2017-2022 (KG)

Figure 27. Americas Mupirocin Revenue 2017-2022 ($ Millions)

Figure 28. APAC Mupirocin Sales 2017-2022 (KG)

Figure 29. APAC Mupirocin Revenue 2017-2022 ($ Millions)

Figure 30. Europe Mupirocin Sales 2017-2022 (KG)

Figure 31. Europe Mupirocin Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Mupirocin Sales 2017-2022 (KG)

Figure 33. Middle East & Africa Mupirocin Revenue 2017-2022 ($ Millions)

Figure 34. Americas Mupirocin Sales Market Share by Country in 2021

Figure 35. Americas Mupirocin Revenue Market Share by Country in 2021

Figure 36. United States Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Mupirocin Sales Market Share by Region in 2021

Figure 41. APAC Mupirocin Revenue Market Share by Regions in 2021

Figure 42. China Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Mupirocin Sales Market Share by Country in 2021

Figure 49. Europe Mupirocin Revenue Market Share by Country in 2021

Figure 50. Germany Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Mupirocin Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Mupirocin Revenue Market Share by Country in 2021

Figure 57. Egypt Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Mupirocin Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Mupirocin in 2021

Figure 63. Manufacturing Process Analysis of Mupirocin

Figure 64. Industry Chain Structure of Mupirocin

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390